000 | 01945 a2200541 4500 | ||
---|---|---|---|
005 | 20250517134247.0 | ||
264 | 0 | _c20171016 | |
008 | 201710s 0 0 eng d | ||
022 | _a1557-3125 | ||
024 | 7 |
_a10.1158/1541-7786.MCR-16-0101 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, Se-Lim | |
245 | 0 | 0 |
_aCombined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation. _h[electronic resource] |
260 |
_bMolecular cancer research : MCR _c02 2017 |
||
300 |
_a141-151 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarcinogenesis _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aColitis _xdrug therapy |
650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMesalamine _xadministration & dosage |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhenylhydrazines _xadministration & dosage |
650 | 0 | 4 |
_aSesquiterpenes _xadministration & dosage |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aKim, Seong Hun | |
700 | 1 | _aPark, Young Ran | |
700 | 1 | _aLiu, Yu-Chuan | |
700 | 1 | _aKim, Eun-Mi | |
700 | 1 | _aJeong, Hwan-Jeong | |
700 | 1 | _aKim, Yo Na | |
700 | 1 | _aSeo, Seung Young | |
700 | 1 | _aKim, In Hee | |
700 | 1 | _aLee, Seung Ok | |
700 | 1 | _aLee, Soo Teik | |
700 | 1 | _aKim, Sang-Wook | |
773 | 0 |
_tMolecular cancer research : MCR _gvol. 15 _gno. 2 _gp. 141-151 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1541-7786.MCR-16-0101 _zAvailable from publisher's website |
999 |
_c26804879 _d26804879 |